Listening and learning from women about mifepristone: implications for counseling and health education.
The careful, reflective, and honest way in which the women in the study analyzed, questioned, and explored the benefits and disadvantages of a mifepristone abortion compared with vacuum aspiration yielded an extensive list of information needed by women to make informed choices as well as an understanding of the diverse social contexts in which choices are made. Needed information identified by this study included technical information about the drugs themselves and their mechanisms of action, roles and responsibilities of health personnel, and descriptions of other women's experiences with mifepristone. A multiplicity of factors entered the decision-making process, demonstrating at the same time a complexity and flexibility of thought. In their hypothetical evaluation of mifepristone, women weighed such factors as experience with childbirth, spontaneous abortion and vacuum aspiration, specific issues for teenagers, lack of a support system, experience with herbal emenagogues and nonprescription drugs intended as abortifacients, and the relative dependence on health care providers. Social, personal, and cultural factors entered into women's interpretation of the different options. These socio-cultural contexts can profoundly influence decisions and potentially affect clinical outcomes. If health care professionals are not proactive, do not fully provide answers to questions (even if unasked), and fail to probe for specific life circumstances, then poor choices and poor outcomes may follow with long term negative consequences for clients.(ABSTRACT TRUNCATED AT 250 WORDS)
Castle
M A
MA
Planned Parenthood of New York City, Inc., New York, USA.
Harvey
S M
SM
Beckman
L
L
Coeytaux
F
F
Garrity
J M
JM
D000021:Abortifacient Agents, Steroidal / Q000008:administration & dosage*; D000328:Adult; D001294:Attitude to Health; D003376:Counseling; D003657:Decision Making; D005260:Female; D017144:Focus Groups; D006301:Health Services Needs and Demand; D006801:Humans; D015735:Mifepristone / Q000008:administration & dosage*; D010353:Patient Education as Topic; D018570:Risk Assessment
D000021:Abortifacient Agents, Steroidal; D015735:Mifepristone